Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

SM de la Monte - Current Alzheimer Research, 2012 - ingentaconnect.com
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …
被引用次数：587 相关文章
[PDF] scienceopen.com

[PDF][PDF] Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

SM de la Monte - Current Alzheimer Research, 2012 - scienceopen.com
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …
[PDF] semanticscholar.org

[PDF][PDF] Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

SM de la Monte - Current Alzheimer Research, 2012 - pdfs.semanticscholar.org
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

SM de la Monte - Current Alzheimer research, 2012 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …

[引用][C] Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease

SM de la Monte - Current Alzheimer Research, 2012 - cir.nii.ac.jp
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
[HTML] nih.gov

[HTML][HTML] Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

SM de la Monte - Current Alzheimer Research, 2012 - ncbi.nlm.nih.gov
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …
[PDF] alz-disease.org

[PDF][PDF] Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

SM de la Monte - Current Alzheimer Research, 2012 - alz-disease.org
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.

SM de la Monte - Current Alzheimer Research, 2012 - europepmc.org
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …
[PDF] psu.edu

[PDF][PDF] Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

SM de la Monte - Current Alzheimer Research, 2012 - Citeseer
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.

SM de la Monte - Current Alzheimer Research, 2012 - europepmc.org
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …